1998/1999 Publications Page |
1998/1999 Publications Page |
1. Al-Chalabi A, Andersen PM, Chioza B, Shaw C, Sham PC, Robberecht W, Matthijs G, Camu W, Marklund SL, Forsgren L, Rouleau GA, Laing NG, Hurse PV, Siddique T, Leigh PN, and Powell JF: Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: evidence for a linked protective factor. Human Molecular Genetics 7:2045-2050, 1998.
2. Adjalla CA, Hosack AR, Gilfix BM, Sun S, Evans S, Matiaszuk NV and Rosenblatt DS: Seven Novel Mutations in mut methylmalonic aciduria. Hum Mut 11:270-274, 1998.
3. Adjalla CE, Hosack AR, Matiaszuk NV and Rosenblatt DS: A common mutation among Blacks with mut- methylmalonic aciduria. Hum Mut 1:S248-S250, 1998.
4. Boright AP, Connelly PW, Brunt JH, Morgan K, and Hegele RA: Association and linkage of LDLR gene variation with variation in plasma low density lipoprotein cholesterol. J Hum Genet 43:153-159, 1998.
5. Bouchard J-P, Richter A, Mathieu J, Brunet D, Hudson TJ, Morgan K and Melançon SB: Autosomal recessive spastic ataxia of Charlevoix-Saguenay. Neuromuscular Disorders 8: 474-479, 1998.
6. Bouchard L, Boukaftane Y, Bétard C, Hudson TJ and Mitchell GA: The human mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase gene (HMGCS2): characterization of an intragenic microsatellite (D1S3752) in French-Canadians and gene mapping with radiation hybrids. Human Mutation 12(4): 291, 1998.
7. BoukaftaneY, Khoris J, Moulard B, Salachas F, Meninger V, Malafosse A, Camu W and Rouleau GA: Identification of Six Novel SOD1 Gene Mutations in Familial Amyotrophic Lateral Sclerosis Patients. Can J Neurol Sci 25:192-196, 1998.
8. Bourgault C, Suissa S, Elstein E, and Lelorier J: Reference based pricing of pharmaceuticals: Assessing therapeutic equivalence of ACE inhibitors. CMAJ (in press) 1999.
9. Brais B, Bouchard JP, Xie Y, Rochefort D, Chrétien N, Tomé F, Lafreniere R, Rommens J, Uyama E, Nohira O, Blumen S, Korcyn A, Heutink P, Mathieu J, Duranceau A, Codere F, Fardeau M, Rouleau GA. Short GCG expansions in the PAB2 Gene Cause Oculopharyngeal Muscular Dystrophy. Nature Genetics 18:164-167, 1998.
10. Brunet J, Ghadirian P, Rebbek TR, Lerman CE, Garber JE, Tonin PN, Abrahamson J, Foulkes WD, Daly M, Wagner-Costalas J, Godwin A, Olopade F, Moselehi R, Liede A, Futreal PA, Weber BL, Lenoir GM, Lynch HT, and Narod SA: The effect of smoking on breast cancer in BRCA1 and BRCA2 carriers. J Natl Cancer Inst 90: 761-766, 1998.
11. Cantarovich M, de Gruchy, Forbes C, Marpole D, Elstein E, Magnan, de Varennes: Optimal timing for surveillance endomyocardial biopsies in heart transplant patients receiving antithymocyte globulin induction. Transplantation Proceedings 31: 79, 1999.
12. Christensen B, Arbour L, Tran P, Leclerc D, Sabbaghian N, Platt R, Gilfix BM, Rosenblatt DS, Gravel RA, Forbes P and Rozen R: Genetic polymorphisms in methlenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Amer J Med Genet 84:151-157, 1999.
13. de Andrade M, Amos CI and Foulkes WD: Segregation analysis of squamous cell carcinoma of the head and neck: evidence for a major gene determining risk. Ann Hum Genet 62: 505-510, 1998.
14. Deloukas P, Schuler GD, Gyapay G, Beasley EM, Soderlund C, Rodriguez-Tome P, Hui L, Matise TC, McKusick KB, Beckmann JS, Bentolila S, Bihoreau M-T, Birren BB, Browne J, Butler A, Castle AB, Chiannikulchai N, Clee C, Day PJR, Dehejia A, Dibling T, Drouot N, Duprat S, Fizames C, Fox S, Gelling S, Green L, Harrison P, Hocking R, Holloway E, Hunt S, Keil S, Lijnzaad P, Louis-Dit-Sully C, Ma J, Mendis A, Miller J, Morissette J, Muselet D, Nusbaum HC, Peck A, Rozen S, Simon D, Slonim DK, Staples R, Stein LD, Stewart EA, Suchard MA, Thangarajah T, Vega-Czarny N, Webber C, Wu X, Auffray C, Nomura N, Sikela JM, Polymeropoulos MH, James MR, Lander ES, Hudson TJ, Myers RM, Cox DR, Weissenbach J, Boguski MS, and Bentley DR: A Physical Map of 30,000 human genes. Science 282: 744-746, 1998.
15. Dong J, Chang-Claude J, Wu Y, Schumaker V, Debatin I, Tonin P, and Royer-Pokora B: A high proportion of recurrent and novel mutations in the BRCA1 gene in German breast/ovarian cancer families with clustering of mutations in the 3' third of the gene. Hum Genet 103: 154-161, 1998.
16. Eeles RA, Simard J, Teare D, Edwards S, Durocher F, Badzioch M, Hamoudi R, Gill S, Biggs P, Dearnaley D, Arden-Jones A, Dowe A, Shearer R, Ford D, Amos C, The CRC/BPG Familial Prostate Cancer Study Collaborators, Ghadirian P, Aprikian A, Norman R, McLellan D, Labrie F, Narod SA, Easton D and Foulkes W: Linkage analysis of chromosome 1q markers in 136 prostate cancer families. Am J Hum Genet 62: 653-658, 1998.
17. Feit H, Silbergleit A, Schneider LB, Gutierrez JA, Fitoussi R-P, Réyès C, Rouleau GA, Brais B, Jackson CE, Beckmann JS, and Seboun E: Vocal cord and pharyngeal weakness with autosomal dominant distal myopathy: clinical description and gene localization to 5q31. Amer J Hum Genet 63:1732-1742, 1998.
18. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BAJ, Gayther S, Birch SM, Indbloom A, Stoppa-Lyonet D, Bignon Y, Borg A, Hamman U, Haites N, Scott RJ, Maygard CM, Vasen H, Seitz S, Cannon-Albright LA, Schofield A, and Hedman MZ: The Breast Cancer Linkage Consortium. 1998. Genetic heterogeneity and penetrance analysisof BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62: 676-689.
19. Godard B, Foulkes WD, Provencher D, Brunet J-S, Tonin PN, Mes-Masson, A-M, Narod SA and Ghadirian P: Risk factors for familial and sporadic ovarian cancer among French-Canadians: a case-control study. Amer J Obstet Gynecol 179: 403-410, 1998.
20. Goyette, P., Rosenblatt, D.S. and Rozen, R.: Homocystinuria (methylenetetrahydrofolate reductase deficiency) and Mutations of Factor V Gene. J Inhert Dis 21:690-691, 1998.
21. Hudson TJ: The Human Genome Project: tools for the identification of disease genes. Clin Invest Med 21 (6): 267-276, 1998.
22. Israels SJ and Gilfix BM: Alpha1-antitrypsin deficiency presenting with fatal intracranial hemorrhage in a newborn. J Pediatric Hematology/Oncology 1999; (in press).
23. Joober R, Benkelfat C, Brisebois K, Toulouse A, Lafreniere R, Turecki G, Lal S, Bloom D, Labelle A, Lalonde P, Fortin D, Alda M, Palmour R, and Rouleau GA: Lack of Association Between the hSKCa3 Channel Gene CAG Polymorphism and Schizophrenia. Neuropsychiatric Genetics 88:154-157, 1999.
24. Joober R, Benkelfat C, Brisebois K, Toulouse A, Turecki G, Lal S, Bloom D, Labelle A, Lalonde P, Fortin D, Alda M, Palmour R, and Rouleau GA: T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability. Journal of Psychiatry and Neuroscience 24:141-146, 1999.
25. Joober R, Benkelfat C, Jannatipour M, Turecki G, Lal S, Mandel J, Bloom D, Lalonde P, Lopes-Cendes I, Fortin D, and Rouleau G: Polyglutamine-containing proteins in schizophrenia. Molecular Psychiatry 4:53-57, 1999.
26. Kasprzak L, Der Kaloustian VM, Elliott AM, Shevell M, Lejtenyi C, Eydoux P: Deletion of 22q11 in two brothers with different phenotype. Amer J Med Genet 75:288-291, 1998.
27. Kasprzak L, Foulkes WD, Shelling AN: Hereditary ovarian carcinoma. Clinical review. British Medical Journal 318: 786-789, 1999.
28. Kenmochi N, Kawaguchi T, Rozen S, Davis E, Goodman N, Hudson TJ, Tanaka T and Page DC: A map of 75 human ribosomal protein genes. Genome Research 8(5): 509-523, 1998.
29. Kerr B, Foulkes WD, Cade D, Hadfield L, Hopwood P, Serruya C, Hoare F, Narod SA and Evans DG: False family history of breast cancer in the family cancer clinic. Eur J Surg Oncol 24: 275-279, 1998.
30. Kibar Z, Lafreniere R, Chakravarti A, Wang J, Chevrette M, Der Kaloustian V, and Rouleau GA: A Radiation Hybrid Map of 48 Loci Including the Clouston Hidrotic Ectodermal Dysplasia (HED) Locus in the Pericentromeric Region of Chromosome 13q. Genomics 56:127-130, 1999.
31. King BL, Sirugo G, Nadeau JH, Hudson TJ, Kidd KK, Kacinski BM and Schalling M: Long CAG/CTG repeats in mice. Mammalian Genome 9:392-393, 1998.
32. Kish SJ, Lopes-Cendes I, Guttman M, Furukawa Y, Pandolfo M, Rouleau GA, Ross B, Nance M, Schut L, Ang L, and DiStefano L: Brain glyceraldehyde-3-phosphate dehydrogenase activity in human trinucleotide repeat disorders. Archives of Neurology 55:1299-1304, 1998.
33. Leclerc D, Wilson A, Dumas R, Gafuik C, Song D, Watkins D, Heng HHQ, Rommens JM, Scherer SW, Rosenblatt DS and Gravel RA: Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc. Natl. Acad. Sci. USA. 95: 3059-3064, 1998.
34. Lounis H, Mes-Masson A-M, Dion F, Bradley WE, Seymour RJ, Provencher D, Tonin PN: Mapping of chromosome arm 3p deletions in human epithelial ovarian cancers. Oncogene 17: 2359-2366, 1998.
35. Manning A, Mes-Masson A-M, Seymour RJ, Tetrault M, Provencher D, Tonin PN: Expression of FHIT in primary cultures of human epithelial ovarian tumours and malignant ascites. Molecular Carcinogenesis 24: 218-225, 1999.
36. Mezei M, Mankodi A, Brais B, Marineau C, Thornton C, Rouleau GA, and Karpati G: Subclinical (GCG) Trinucleotide Expansion in the PABP2 Gene is Not a Predisposing Genetic Factor for Sporadic Inclusion Body Myositis. Neurology 52:669-670, 1999.
37. Mohandas N, Hoover K, Tsukita S, Takakuwa Y, Huang S, Arpin M, Benz E, Louvard D, Bretscher A, Tonks N, Ramesch V, Fehon R, Anderson J, Gusella J, Fanning A, Chisti A, Kim A, Mafatia S, Lutchman M, Hanspal M, Jindal H, Chasis J, Liu S, Low P, Rouleau GA, Bryant P, Solomon F, Conboy J, Woods D, and Gascard P: The FERM Domain: a Unique Module Involved in the Linkage of Cytoplasmic Proteins to the Membrane. Trends in Biochemical Sciences 23:281-282, 1998.
38. Minassian B, Lee J, Herbrick J, Huizenga J, Soder S, Mungall A, Dunham I, Gardner R, Fong CY, Carpenter S, Jardim L, Staishchandra P, Andermann E, Snead O, Lopes-Cendes I, Tsui LC, Delgado-Escueta A, Rouleau GA, and Scherer S: Mutations in a Gene Encoding a Novel Protein Tyrosine Phosphatase Cause Progressive Myoclonus Epilepsy. Nature Genetics 20:171-174, 1998.
39. Mulders SM, Bichet DG, Rijss JPL, Kamsteeg E-J, Arthus M-F, Lonergan M, Fujiwara M, Morgan K, Leijendekker R, van der Sluijs P, van Os CH, and Deen PMT: An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex. J Clin Invest 102:57-66, 1998.
40. Narod SA, Risch H, Moslehi R, Dorum A, Neuhausen S, Moller P, Olsson H, Provencher D, Radice P, Evans G, Bishop S, Brunet J-S, Ponder B, for the Hereditary Ovarian Cancer Clinical Study Group*. 1998. Oral Contraceptive use reduces the risk of hereditary ovarian cancer. N Engl J Med 339: 424-426.(*Tonin PN: member)
41. Naumova AK, Leppert M, Barker D, Morgan K, and Sapienza C: Parental-origin-dependent, male offspring-specific, transmission-ratio distortion at loci on the human X chromosome. Amer J Hum Genet 62:1493-1499, 1998.
42. Naumova AK, Olien L, Bird LM, Smith M, Verner AE, Leppert M, Morgan K, and Sapienza C: Genetic mapping of X-linked loci involved in skewing of X chromosome inactivation in the human. Eur J Hum Genet 6:552-562, 1998.
43. Pal T, Flanders T, Lehman M, McMillan A, Brunet J-S, Narod SA and Foulkes, WD: Genetic implications of double primary cancers of the colorectum and endometrium J Med Genet 35: 978-984, 1998.
44. Pereira P, Stanton V, Jothy S, Tomlinson IPM, Foulkes WD and Rozen R: Loss of heterozygosity of methylenetetrahydrofolate reductase in colon carcinomas. Oncology Reports 6: 597-599, 1999.
45. Pollock PM, Spurr N, Bishop DT, Newton-Bishop J, Gruis N, Goldstein AM, Tucker MA, Foulkes WD, Barnhill R, Haber D, Fountain J and Hayward NK: Haplotype analysis of 2 recurrent CDKN2A mutations in 10 melanoma families from three continents-evidence for common founders. Hum Mutation 11:424-431, 1998.
46. Provencher D, Ghadirian P and Narod SA: Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Am J Hum Genet 63: 1341-1351. 1998.
47. Quantz M, deVarennes B, Elstein E, Ergina P, Magnan C, et al: Neoral dose monitoring with cyclosporine 2 hours post dose levels in heart transplant patients receiving thymoglobuline induction. Transplantation (submitted).
48. Redston M, Nathanson KC, Yuan ZQ, Neuhausen SL, Satagopan J,Wong N, Abrahamson J, Yang D, Nafa D, Antin-Ozerkis D,Ozcelik H, Andrulis I, Daly M, Pinsky L, Schrag D, Gallinger S, Kaback M, King M-C, Woodage T, Brody LC, Godwin A, Warner E, Weber B, Foulkes W and Offit K: The APC I1307K allele and breast cancer risk. Nature Genetics 20: 13-14, 1998.
49. Rioux JD, Daly MJ, Green T, Stone V, Lander ES, Hudson TJ, Steinhart AH, Bull S, Cohen Z, Greenberg G, Griffiths A, McLeod R, Silverberg M, Williams CN and Siminovitch KA: Absence of linkage between inflammatory bowel disease and selected loci on chromosomes 3, 7, 12, and 16. Gastroenterology 115: 1062-1065, 1998.
50. Rioux JD, Stone VA, Daly MJ, Cargill M, Green T, Nguyen H, Nutman T, Zimmerman PA, Tucker MA, Hudson T, Goldstein AM, Lander E and Lin AY: Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-q33. American Journal of Human Genetics 63: 1086-1094, 1998.
51. Sebastiani G, Olien L, Gauthier S, Skamene E, Morgan K, Gros P, and Malo D: Mapping of genetic modulators of natural resistance to infection with Salmonella typhimurium in wild-derived mice. Genomics 47:180-186, 1998.
52. Sequeiros J, Maciel P, Taborda F, Ledo S, Rocha J, Lopes A, Reto F, Fortuna A, Rousseau M, Fleming M, Coutinho P, Rouleau GA and Jorge C: Prenatal Diagnosis of Machado-Joseph Disease by Direct Mutation Analysis. Prenat Diag 18:611-617, 1998.
53. Sniderman LC, Lambert M, Giguère R, Auray-Blais C, Lemieux, Laframboise R, Rosenblatt DS and Treacy EP: Outcome of individuals with low-moderate methylmalonic aciduria detected through a neonatal screening program. J Pediatr 134: 675-680, 1999.
54. Tonin PN, Mes-Masson A-M, Futreal PA, Morgan K, Mahon M, Foulkes WD, Cole DEC, Provencher D, Ghadirian P, and Narod SA: Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Amer J Hum Genet 63:1341-1351, 1998.
55. Tonin PN, Mes-Masson A-M, Futreal PA, Morgan K, Mahon M, Foulkes WD, Cole DEC, Adjalla CE, Hosack AR, Gilfix BM, Lamothe E, Sun S, Chan A, Evans S, Matiaszuk NV, Rosenblatt DS: Seven novel mutations in mut methylmalonic aciduria. Hum Mutat 11: 270-274, 1998.
56. Turecki G, Rouleau GA, Mari JJ, Joober R, and Morgan K: Letter to the Editor: reply to Bellivier et al. "Methodological problems in meta analysis of association studies between bipolar affective disorder and the tyrosine hydroxylase gene." Amer J Med Genet 81:351-352, 1998.
57. Turecki G, Grof P, Cavazzoni P, Duffy A, Grof E, Ahrens B, Berghöfer A, Müller-Oerlinghausen B, Dvoráková M, Libigerová E, Vojtechovský M, Zvolský P, Joober R, Nilsson A, Prochazka H, Licht RW, Rasmussen NA, Schou M, Vestergaard P, Holzinger A, Schumann C, Thau K, Rouleau GA and Alda M: Preliminary Evidence for a Role of Phospholipase C-g1 in the Pathogenesis of Bipolar Disorder Responsive to Lithium. Molecular Psychiatry 3:534-539, 1998.
58. Wang DG, Fan J-B, Siao C-J, Berno A, Young P, Sapolsky R, Ghandour G, Perkins N, Winchester E, Spencer J, Kruglyak L, Stein L, HsieL, Topalogolu T, Hubbell E, Robinson E, Mittman M, Morris MS, Shen N, Kilburn D, Rioux J, Nusbaum C, Rozen S, Hudson TJ, Lipshutz R, Chee M and Lander ES: Large-scale identification, mapping and genotyping of single-nucleotide polymorphisms in the human genome. Science 280: 1077-1082, 1998.
59. Watkins D: Cobalamin metabolism in methionine-dependent human tumour and leukemia cell lines. Clin Invest Med 21:151-158, 1998.
60. Weiler T, Greenberg CR, Zelinski T, Nylen E, Coghlan G, Crumley J, Fujiwara TM, Morgan K, and Wrogemann K: A gene for autosomal recessive limb-girdle muscular dystrophy in Manitoba Hutterites maps to chromosome region 9q31-q33: evidence for another limb-girdle muscular dystrophy locus. Amer J Hum Genet 63:140-147, 1998.
61. Wilson A, Leclerc D, Saberi F, Phillips III JA, Rosenblatt DS and Gravel RA: Functionally null mutations in patients with the cblG variant form of methionine synthase deficiency. Amer J Hum Genet 63:409-414, 1998.
62. Xiao S, Nalabolu SR, Aster JC, Ma J, Abruzzo L, Jaffe ES, Stone R, Weissman SM, Hudson TJ and Fletcher JA: FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome. Nature Genetics 18: 84-87, 1998.
63. Xie Y, Rochefort D, Brais B, Howard H, Han F, Gou L, Maciel P, Larsson C, and Rouleau GA: Restriction map of a YAC and cosmid contig encompassing the oculopharyngeal muscular dystrophy candidate region on chromosome 14q11.2-q13. Genomics 52:201-204, 1998.
64. Zhu JJ, Santarius T, Wu X, Tsong J, Guha A, Wu JK, Hudson TJ and Black PMcL: Screening for loss of heterozygosity and microsatellite instability in oligodendrogliomas. Genes Chromosomes and Cancer 21: 207-216, 1998.
65. Zhi Qiang Y, Kasprzak L, Gordon PH, Pinsky L, Foulkes W: I1307K APC and hMLH1 mutations in a non-Jewish family with hereditary non-polyposis colorectal cancer. Clinical Genetics 54:368-370, 1998.
1. Flanders TY and Foulkes WD: Cancers of the digestive system. In: Inherited susceptibility to cancer: clinical, predictive and ethical perspectives. Foulkes WD and SV Hodgson (eds). Cambridge University Press, 1998.
2. Foulkes WD and Hodgson: Late-breaking developments. In: Inherited susceptibility to cancer: clinical, predictive and ethical perspectives. Foulkes WD and SV Hodgson (eds). Cambridge University Press, 1998.
3. Foulkes WD and Narod SA: Cancers of the breast, ovary and uterus. In: Inherited susceptibility to cancer: clinical, predictive and ethical perspectives. Foulkes WD and SV Hodgson (eds). Cambridge University Press, 1998.
4. Rosenblatt DS: Prenatal Diagnosis of the inborn errors of folate and cobalamin metabolism and cystinosis, in Genetics Disorders and the Fetus: Diagnosis, Prevention and Treatment A. Milunsky, (ed.) 4th edition, Johns Hopkins University Press, 1998, pp 550-562.
5. Rosenblatt DS and Hoffbrand AV: Megaloblastic anemia and disorders of cobalamin and folate metabolism, in Pediatric Hematology. J. Lilleyman, I. Hann, V. Blanchette, (eds.) 2nd edition, Churchill Livingstone. In press.
6. Rosenblatt DS and Whitehead VM: Cobalamin and folate deficiency in children: Acquired and hereditary disorders, in Seminars in Hematology. P.A. Miescher, E.R.Jaffé (eds.) W.B. Saunders Co., 36:19-34, 1999.
7. Schalling M, Lindblad K, Yuan Q-P, Burgess CE, Zander C and Hudson TJ (1998). RED Technology. Robert D. Wells & Stephen T. Waven (Eds.): Genetic Instabilities and Hereditary Neurological Diseases. San Diego: Academic Press, 1998, pp 439-446.
1. Bétard C, Mata S, Brewer CG, Ge B, Clark SL, Lei M, Frappier D, Hudson N, Kassis J, Rauch J, Busque L, Ferland D, Fujiwara TM, Morgan K, Hudson TJ and Fortin PR (1998) Autoimmune lupus-like phenotype: a challenging complex trait. Evidence for linkage to chromosome 1q region. Submitted for the Canadian Genetic Diseases Network Annual Meeting, May 5-8, 1998, St. Sauveur, Quebec.
2. Bétard C, Mata S, Brewer C, Ge B, Clark S, Lei M, Hudson N, Kassis J, Rauch J, Busque L, Ferland D, Fujiwara M, Morgan K, Hudson TJ, and Fortin PR: Autoimmune lupus-like anbnormaility: a challenging complex trait. Evidence for linkage to chromosome 1q region. "Qui fait quoi?" Les Journées Génétiques `98, Le Réseau de médecine génétique appliquée du Québec, p 73, May 21-22, 1998, Montreal, Quebec.
3. Bichet, D, Fujiwara M, Arthus M-F, Lonergan M, Turner M, Crumley J, and Morgan K: The spectrum of diabetes insipidus mutations and the importance of early recognition and treatment. "Qui fait quoi?" Les Journées Génétiques `98, Le Réseau de médecine génétique appliquée du Québec. P 31, May 21-22, 1998.
4. Bichet DG, Arthus M-F, Lonergan M, Morgan K, and Fujiwara TM: Hereditary central diabetes insipidus: autosomal dominant and autosomal recessive phenotypes due to mutations in the prepro-AVP-NPII gene. Abstract #A1970: 31st Annual Meeting, Philadelphia, 25-28 October 1998. J Amer Soc Nephr 9 (Program and Abstracts Issue):386A, 1998.
5. Bichet, DG, Lonergan M, Arthus MF, Crumley J, Michaud A, Turner M, Morgan K, and Fujiwara TM: The spectrum of nephrogenic diabetes insipidus mutations and the importance of early recognition and treatment. Abstract #A1971: 31st Annual Meeting, Philadelphia, 25-28 October 1998. J Amer Soc Nephr 9 (Program and Abstracts Issue):386A, 1998.
6. Brais B, Bouchard J-P, Jomphe M, Desjardins B, Mathieu J, Morgan K, and Rouleau G: Description d'une nouvelle méthode de micro-localisation de mutations qui repose sure l'analyse d'haplotypes et de généalogie informatisée et son utilisation dans la localisation du gène de la DMOP. "Qui fait quoi?" Les Journées Génétiques `98, Le Réseau de médecine génétique appliquée du Québec. Montréal, p 55, May 21-22,1998.
7. Brais B, Bouchard JP, Jomphe M, Desjardins B, Dube MP, Tome FMS, Fardeau M, Brunet G, Mathieu J, Prevost C, Pericak-Vance M, Bulman DE, Morgan K, and Rouleau GA: When genetics and history converge: the fine-mapping, North American introduction and diffusion of the French Canadian oculopharyngeal muscular dystrophy mutation. 48th Annual Meeting of the American Society of Human Genetics, 27-31 November 1998, Denver, Amer J Hum Genet 63(Suppl):A43, 1998.
8. Cantarovich M, Quantz M, Elstein E, Ergina P, Magnan C et al. Neoral dose monitoring with 2 hour post-dose levels in heart transplant patients receiving antithymocyte globulin induction: A pilot study. 17th Annual Meeting of the American Society of Transplant Physicians. May 7-12, 1998.
9. Charbonneau F, Elstein E, Overhiser RW, Haber H, Anderson TJ. Differential effects of ACE inhibitors on endothelial dysfunction in coronary disease: Response to Quinapril predicted by ACE genotype. European Society of Cardiology. August 23, 1998.
10. Charbonneau F, Elstein E, Overhiser RW, Haber H, Anderson TJ. Differential effects of ACE inhibitors on endothelial dysfunction in coronary disease: Response to Quinapril predicted by ACE genotype. Canadian Cardiovascular Society. October 20- 24, 1998.
11. Elstein E, Huan C, Fitchett D, Cantarovich M, Marpole D. C677T Gene Mutation in Methylenetetrahydrofolate Reductase as a risk factor for cardiac allograft vasculopathy. The Transplantation Society 17th World Congress. July 12-17, 1998.
12. Engert JC, Ge B, Mercier J, Doré C, Owen C, Bétard C, Morgan K, Hudson TJ and Richter A (1998). Positional cloning of the gene responsible for ARSACS. Oral presentation at the Postdoctoral Fellows Research Day, Dept. of Human Genetics, McGill University, March 18, 1998.
13. Gagnon J-S, Hupe P, Arthus M-F, Lonergan M, Nawar T, Morgan K, Fujiwara TM, and Bichet DG: PKD1 mutations and polymorphisms in French-Canadian families. Abstract #A1905: 31st Annual Meeting, Philadelphia, 25-28 October 1998. J Amer Soc Nephr 9 (Program and Abstracts Issue):373A, 1998.
14. Giguere Y, Dodin S, Blanchet C, Dumont M, Morgan K, and Rousseau F: Associations between bone density and vitamin D and estrogen receptor polymorphisms in postmenopausal women from the Quebec population. Seventh Annual Meeting of the International Genetic Epidemiology Society, Arcachon, France, 11-12 September 1998, Abstract 77. Genetic Epidemiology 15:541, 1998.
15. Goobie S, Morrison J, Ellis L, Ginzberg H, Corey M, Masuno M, Imaizumi K, Kuroki Y, Fujiwara TM, Morgan K, Durie P and Rommens JM: Exclusion of candidate regions on chromosome 6q and 12q in families with Shwachman-Diamond syndrome. 48th Annual Meeting of the American Society of Human Genetics, 27-31 November 1998, Denver, Amer J Hum Genet 63(Suppl):A291, 1998.
16. Ge B, Brewer C, Bétard C, Mata S, Clark S, Darmond-Zwaig C, Hudson N, Kassis J, Rauch J, Busque L, Ferland D, Fujiwara M, Morgan K, Hudson TJ and Fortin PR (1998). Evidence for genetic linkage to chromosome 1q region in human systemic lupus erythematosus. Oral presentation at the Postdoctoral Fellows Research Day, Dept. of Human Genetics, McGill University, March 18, 1998.
17. Gilfix BM. Gene polymorphisms, heart disease, and hemodialysis patients. Blood Purif 1998; 16 (suppl 1):59.
18. Gilfix BM. Gene polymorphisms, heart disease, and hemodialysis patients. La Génétique Humaine Au Québec: "Qui Fait Quoi ?" Les Journés de Génétique Humaine RMGA-FRSQ 21-22 mai 1998; 2:113.
19. Gruchy S, Forbes C, Elstein E, Marpole D, de Varennes B et al. Optimal timing for surveillance endomyocardial biopsies in heart transplant patients receiving antithymocyte globulin induction. The Transplantation Society 17th World Congress. July 12-17, 1998.
20. Hudson TJ, Wang D, Gschwend M, Golub T and Lander ES. Analyses génomiques sur puce à ADN. Oral presentation at the "Journées Génétiques ‘98" organized by the Réseau de Médecine Génétique Appliquée, May 21-22, 1998.
21. Kasprzak L, Wong N, Ozaki J, Galvez M, Tonin PN, Rosenblatt DS, and Foulkes WD: "Ascertainment of familial cancers in the McGill hereditary cancer clinics." Les Journées Génétiques. Montréal, Québec, p. 105, May 21-22, 1998.
22. Laprise C, Boulet L-P, Raymond V, Morissette J, Bétard C and Hudson TJ: Analyse génétique de l’asthme. Oral presentation at the "Journées Génétiques ‘98" organized by the Réseau de Médecine Génétique Appliquée, May 21-22, 1998, Montreal, Quebec.
23. Richter A, Engert J, Mercier J, Ge B, Bétard C, Bouchard JP, Mathieu J, Melançon SB, Hudson TJ, and Morgan K: Genetic, physical and transcript mapping of the ARSACS region on chromosome 13q. "Qui fait quoi?" Les Journées Génétiques `98, Le Réseau de médecine génétique appliquée du Québec. Montréal, p 65 May 21-22, 1998.
24. Richter AM, Engert J, Mercier J, Melançon SB, Hudson TJ, and Morgan K: Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS): physical and transcript map of the gene region on chromosome 13q12. 48th Annual Meeting of the American Society of Human Genetics, November 27-31, Denver, Amer J Hum Genet 63(Suppl):A257, 1998.
25. Rousseau F, Dombrowski C, Lévesque S, Morel M-L, and Morgan K: Génétique moléculaire et des populations du syndrome de retard mental hereditaire avec X-fragile. "Qui fait quoi?" Les Journées Génétiques `98, Le Réseau de médecine génétique appliquée du Québec. Montréal, p 47, 21-22 May 1998.
26. Rozen R, Christensen B, Arbour L, Tran P, Sabbaghian, Platt R, Gilfix B, Rosenblatt D, and Forber P: Interaction between MTHFR genotype and folate status in risk for spina bifida. La Génétique Humaine Au Québec: "Qui Fait Quoi ?" Les Journés de Génétique Humaine RMGA-FRSQ 21-22 mai 1998; 2:33.
27. Tonin PN, Mes-Masson A-M, Provencher D, Foulkes W, Morgan K, Narod S, and Ghadirian P: Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Les Journées Génétiques `98, Le Réseau de médecine génétique appliquée du Québec. Montréal, p 51, May 21-22, 1998.
28. Wang XL, Solymoss S, Gilfix BM. Screening for the Factor V Leiden mutation using Activated Protein C Resistance Ratio.Society for Inherited Metabolic Disorders. Annual Meeting March 12 -15, 1999.
29. Wrogemann K, Franzmann TL, Illarioshkin SN, Ivanova-Smolenskaya IA, Fujiwara TM, Morgan K, Weiler T, Sudha T, Nylen E, and Greenberg CR: Segregation of limb girdle muscular dystrophy (LGMD2B) and distal (Miyoshi) myopathy with the same homozygous haplotypes suggests the influence of modifier gene(s). (Abstract #16: IXth International Congress on Neuromuscular Diseases, Adelaide, 30 August - 4 September 1998) Muscle and Nerve, Supplement 7:S137, 1998.
30. Wrogemann K, Weiler T, Sudha T, Zelinski T, Nylen E, Coghlan G, Crumley J, Fujiwara TM, Morgan K, and Greenberg CR: A gene for autosomal recessive limb girdle muscular dystrophy in Manitoba Hutterites maps to chromosome region 9q31 - q33: evidence for another LGMD locus. (Abstract #17: IXth International Congress on Neuromuscular Diseases, Adelaide, 30 August - 4 September 1998) Muscle and Nerve, Supplement 7:S138, 1998.
1. Foulkes WD, Wong N, Rozen F, Brunet, J-S and Narod SA: Breast cancer survival in BRCA1 carriers. Lancet 351: 1359, 1998.(Letter).
2. Jefferies S, Eeles R, Goldgar D, A'Hern R, Henk JM, Gore M, Rhys-Evans P, Archer D, Bishop K, Murkin A, Solomon E, Hodgsun S, O'Connell M, Hibbert J, Easton D and Foulkes W: The role of genetic factors in predisposition to squamous cell cancer of the head and neck. Br J Cancer 79: 865-7, 1999.(Review).
3. Kasprzak L, Foulkes WD and Shelling AN: Hereditary ovarian carcinoma. BMJ 318: 786-789, 1999. (Review).
4. Liede A, Tonin PN, Serruya C, Sun CC, Narod SA and Foulkes WD: Is hereditary site-specific ovarian cancer a distinct genetic condition? Am J Med Genet 75: 55-58, 1998.(Case Report).
5. Yuan ZQ, Kasprzak L, Gordon PH, Pinsky L and Foulkes, WD: I1307K APC and hMLH1 mutations in a non-Jewish family with hereditary non-polyposis colorectal cancer. Clin Genet 54: 368-370, 1998.(Letter).
(c)1999 pmn for Finestone Labloratory
